Literature DB >> 10490828

pRB is required for interferon-gamma-induction of the MHC class II abeta gene.

X Zhu1, S Pattenden, R Bremner.   

Abstract

pRB is required for IFN-gamma-induction of MHC class II in human tumor cell lines, providing a potential link between tumor suppressors and the immune system. However, other genes, such as cyclin D1, show pRB-dependency only in tumor cells, so by analogy, pRB may not be necessary for cII-regulation in normal cells. Here, we demonstrate that induction of the mouse MHC class II I-A heterodimer is normal in RB+/+ mouse embryonic fibroblasts (MEFs), but deficient in RB-/- MEFs. Inducibility is restored in RB-/- MEFs stably transfected with wild type RB cDNA or infected with an adenovirus expressing pRB. Thus, involvement of pRB in MHC class II expression is conserved in the mouse and is not an aberrant feature of tumorigenic, aneuploid, human tumor cells. Although cII genes are generally induced in a coordinate fashion, suggesting a common mechanism, we found that pRB was specifically required for induction of the Abeta, but not Aalpha or other MHC cII genes including Ebeta, Ii and H2-Malpha. Finally, IFN-gamma-induction of class II transactivator (CIITA), was pRB-independent, suggesting that pRB works downstream of this master-regulator of MHC class II expression.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10490828     DOI: 10.1038/sj.onc.1202876

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  9 in total

Review 1.  Cell Cycle and Beyond: Exploiting New RB1 Controlled Mechanisms for Cancer Therapy.

Authors:  Erik S Knudsen; Steven C Pruitt; Pamela A Hershberger; Agnieszka K Witkiewicz; David W Goodrich
Journal:  Trends Cancer       Date:  2019-04-30

2.  MHC class II associated stomach cancer mutations correlate with lack of subsequent tumor development.

Authors:  John M Yavorski; George Blanck
Journal:  Mol Clin Oncol       Date:  2017-09-29

3.  Interferon-gamma-induced chromatin remodeling at the CIITA locus is BRG1 dependent.

Authors:  Samantha G Pattenden; Robert Klose; Elizabeth Karaskov; Rod Bremner
Journal:  EMBO J       Date:  2002-04-15       Impact factor: 11.598

4.  Histone deacetylase activity represses gamma interferon-inducible HLA-DR gene expression following the establishment of a DNase I-hypersensitive chromatin conformation.

Authors:  A Osborne; H Zhang; W M Yang; E Seto; G Blanck
Journal:  Mol Cell Biol       Date:  2001-10       Impact factor: 4.272

Review 5.  The RB tumor suppressor at the intersection of proliferation and immunity: relevance to disease immune evasion and immunotherapy.

Authors:  Jack Hutcheson; Agnieszka K Witkiewicz; Erik S Knudsen
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

6.  The class II transactivator requires brahma-related gene 1 to activate transcription of major histocompatibility complex class II genes.

Authors:  Rajini Mudhasani; Joseph D Fontes
Journal:  Mol Cell Biol       Date:  2002-07       Impact factor: 4.272

7.  Beyond the Cell Cycle: Enhancing the Immune Surveillance of Tumors Via CDK4/6 Inhibition.

Authors:  Andrea C Chaikovsky; Julien Sage
Journal:  Mol Cancer Res       Date:  2018-06-22       Impact factor: 5.852

8.  Construction of adenovirus vectors simultaneously expressing four multiplex, double-nicking guide RNAs of CRISPR/Cas9 and in vivo genome editing.

Authors:  Tomoko Nakanishi; Aya Maekawa; Mariko Suzuki; Hirotaka Tabata; Kumiko Sato; Mai Mori; Izumu Saito
Journal:  Sci Rep       Date:  2021-02-17       Impact factor: 4.379

9.  Activation of NF-kB pathway by virus infection requires Rb expression.

Authors:  Maria A Garcia; Pedro Gallego; Michela Campagna; José González-Santamaría; Gloria Martínez; Laura Marcos-Villar; Anxo Vidal; Mariano Esteban; Carmen Rivas
Journal:  PLoS One       Date:  2009-07-30       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.